Webinar March 2025 – Dr. Zumbühl

On Wednesday, March 12, 2025, an online seminar on "Liposomes in Clinical Trials" was held at 3.30 p.m. (CET).

The speaker was Dr. Andreas Zumbühl from InnoMedica AG, Bern, Switzerland.

If you are interested in the slides of the presentation, please get in touch with us!

Abstract

In this webinar I will guide you through the details of three pioneering liposomal drug products, each at different stages of development. We will explore a preclinical liposome designed for shear-sensitive drug delivery, targeting acute cardiovascular events. Then we will discuss a doxorubicin liposomal formulation currently in Phase 2 clinical trials for the treatment of cancer, highlighting the liposome’s potential to improve drug efficiency and reduce systemic toxicity.  And we will focus on a novel liposome in Phase 1 clinical trials aimed at treating Parkinson’s disease. This liposome contains the ganglioside GM1 both as a membrane component as well as an active pharmaceutical ingredient.